Nancy A. Dawson

Lack of correlation between prostate-specific antigen and the presence of measurable soft tissue metastases in hormone-refractory prostate cancer.

S. Steinberg, N. Patronas, O. Sartor, 1996, Cancer investigation.

Prostate specific antigen decline following the discontinuation of flutamide in patients with stage D2 prostate cancer.

O. Sartor, W. Figg, E. Reed, 1995, The American journal of medicine.

A phase I/II study of continuous infusion suramin in patients with hormone-refractory prostate cancer : toxicity and response

O. Sartor, W. Figg, D. Headlee, 1996, Cancer Chemotherapy and Pharmacology.

Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancer.

S. Steinberg, E. Sausville, O. Sartor, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.